Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.
暂无分享,去创建一个
L R Muenz | J. Balow | H A Austin | J E Balow | L. Muenz | H. Austin | K. Joyce | T. Antonovych | K M Joyce | T T Antonovych
[1] A. Cohen,et al. THE NEPHROPATHY OF SYSTEMIC LUPUS ERYTHEMATOSUS: An Assessment by Clinical, Light and Electron Microscopic Criteria , 1967 .
[2] A. Steinberg,et al. Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up. , 1983, Annals of internal medicine.
[3] V. Pollak,et al. Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis. , 1961, The Journal of laboratory and clinical medicine.
[4] D. E. Cheatum,et al. Renal histology and clinical course of systemic lupus erythematosus. A prospective study. , 1973, Arthritis and rheumatism.
[5] K. E. Holley,et al. Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. , 1972, Annals of internal medicine.
[6] A. Steinberg,et al. A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis. , 1974, Arthritis and rheumatism.
[7] A. Steinberg,et al. Systemic Lupus Erythematosus: Evolving Concepts , 1979 .
[8] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[9] D. Droz,et al. The course of lupus nephritis: contribution of serial renal biopsies. , 1976, Advances in nephrology from the Necker Hospital.
[10] N. Ordóñez,et al. Changing histopathology patterns in lupus nephropathy. , 1978, Clinical nephrology.
[11] V. Pollak,et al. THE NATURAL HISTORY OF THE RENAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. , 1964, The Journal of laboratory and clinical medicine.
[12] R. Mccluskey,et al. The clinical course of the proliferative and membranous forms of lupus nephritis. , 1970, Annals of internal medicine.
[13] J. Hayslett,et al. PROGNOSTIC INDICES IN LUPUS NEPHRITIS , 1976, Medicine.
[14] Q. Whiting-O'Keefe,et al. The information content from renal biopsy in systemic lupus erythematosus. , 1982, Annals of internal medicine.
[15] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[16] Elisa T. Lee,et al. Statistical Methods for Survival Data Analysis , 1994, IEEE Transactions on Reliability.
[17] B. Zweiman,et al. The prognosis of lupus nephritis. Role of clinical-pathologic correlations. , 1968, Annals of internal medicine.
[18] A. Steinberg,et al. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months. , 1975, Annals of internal medicine.
[19] P. Armitage,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.
[20] J. Bach,et al. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. , 1978, The American journal of medicine.
[21] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[22] D. Cox. Regression Models and Life-Tables , 1972 .
[23] A. Steinberg,et al. Cyclophosphamide in lupus nephritis: a controlled trial. , 1971, Annals of internal medicine.
[24] D. Baldwin,et al. Lupus nephritis: Clinical course as related to morphologic forms and their transitions , 1977 .
[25] V. Pollak,et al. Lupus nephritis: a clinical and pathologic study based on renal biopsies. , 1957, Medicine.
[26] J. Klippel,et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. , 1983, The American journal of medicine.
[27] D. Wallace,et al. Lupus nephritis: Experience with 230 patients in a private practice from 1950 to 1980 , 1982 .
[28] C. Chantler,et al. Systemic lupus with nephritis: a long-term study. , 1979, The Quarterly journal of medicine.
[29] Balow Je. Therapeutic trials in lupus nephritis. Problems related to renal histology, monitoring of therapy and measures of outcome. , 1981 .
[30] D. Estes,et al. THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS , 1971, Medicine.
[31] V. Pollak,et al. THE REPRODUCIBILITY OF SEMIQUANTITATIVE ANALYSES OF RENAL HISTOLOGY. , 1964, Nephron.
[32] M. Pike,et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.
[33] Striker Ge,et al. The course of lupus nephritis: a clinical-pathological correlation of fifty patients. , 1973 .
[34] M. Liang,et al. Marginal benefit of renal biopsy in systemic lupus erythematosus. , 1978, Archives of internal medicine.
[35] G. Appel,et al. RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A Study of 56 Patients Emphasizing Histologic Classification , 1978, Medicine.
[36] A. Steinberg,et al. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis. , 1982, Annals of internal medicine.
[37] P. Kincaid‐smith,et al. Lupus nephritis: clinical course in relation to treatment. , 1973, Perspectives in nephrology and hypertension.
[38] B. Burke,et al. Systemic lupus erythematosus within the first two decades of life. , 1977, The American journal of medicine.
[39] E. Gehan. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.